GSK set out plans on Wednesday to turn its consumer healthcare business into a separately listed company, aiming to ...

GSK plc GSK recently announced that it has completed the spin-off of its consumer healthcare segment into a new standalone company called Haleon. Following the demerger, Haleon is the world’s largest ...

Come Monday, GSK and consumer health unit Haleon will officially part ways, leaving the Big Pharma's biopharma and vaccines divisions to stand on their own. This will give the drugmaker—and its CEO ...

LONDON - British drugmaker GSK spun off its consumer health business on Monday in the biggest listing in Europe for more than a decade, but the unit's market value of 30.5 billion pounds fell well ...

GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company. About 385 million shares will be sold at a ...

Focused on protecting and returning value of Jemperli and imsidolimab royalties to shareholders Launches with virtual model, including limited FTEs and minimal operating expenses, and approximately ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...